Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease

BACKGROUND: Empagliflozin exerted positive cardiorenal effects in the EMPA-KIDNEY trial; this study reports active trial plus post-trial data. METHODS: In this trial, patients with an estimated glomerular filtration rate 20-<45; or 45-<90mL/min/1.73m(2) and urinary albumin-to-creatinine ratio...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :N Engl J Med
Главные авторы: Herrington, William G., Staplin, Natalie, Agrawal, Nikita, Wanner, Christoph, Green, Jennifer B., Hauske, Sibylle J., Emberson, Jonathan R., Preiss, David, Judge, Parminder, Zhu, Doreen, Dayanandan, Rejive, Arimoto, Ryoki, Mayne, Kaitlin J., Ng, Sarah Y.A., Sammons, Emily, Hill, Michael, Stevens, Will, Wallendszus, Karl, Brenner, Susanne, Cheung, Alfred K., Liu, Zhi-Hong, Li, Jing, Hooi, Lai Seong, Liu, Wen, Kadowaki, Takashi, Nangaku, Masaomi, Levin, Adeera, Cherney, David Z.I, Maggioni, Aldo P., Pontremoli, Roberto, Deo, Rajat, Goto, Shinya, Rossello, Xavier, Tuttle, Katherine R., Steubl, Dominik, Massey, Dan, Brueckmann, Martina, Landray, Martin J., Baigent, Colin, Haynes, Richard
Формат: Artigo
Язык:Inglês
Опубликовано: 2024
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616743/
https://ncbi.nlm.nih.gov/pubmed/39453837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2409183
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы